tradingkey.logo

BUZZ-Medical device maker Tandem falls as 2025 sales forecast mostly flat

ReutersFeb 27, 2025 2:01 PM

Shares of medical device maker Tandem Diabetes Care TNDM.O down 24% at $25.50

Company late on Wednesday forecast 2025 sales between $997 mln and $1.007 bln vs. analysts' average estimate of $1.004 billion, according to data compiled by LSEG

Says "muted seasonality" and "shipping delays" led to softness in demand for co's insulin pumps towards the end of Q4 and expects salesforce disruptions -TNDM

The 2025 outlook reflects the seasonal trends extending into Q1 - RBC Capital analysts

"What will likely cause investor consternation is the lower-than-anticipated Q1 2025 revenue guidance and the implied ramp through the rest of the year" -Brokerage Citi

Company sees Q1 sales to be about $219 million to $224 million compared to analysts' estimate of $221 million

TNDM has risen 16.4% in the last 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI